Want to see IN:ONESOURCE full AI Analyst Report?
OneSource Specialty Pharma Limited (ONESOURCE) Stock Statistics & Valuation Metrics
Total Valuation
OneSource Specialty Pharma Limited has a market cap or net worth of INR 183.44B. The enterprise value is INR 192.09B.
- Market Cap
- INR 183.44B
- Enterprise Value
- INR 192.09B
Share Statistics
OneSource Specialty Pharma Limited has 114,673,790 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 114,673,790
- Owned by Insiders
- ―
- Owned by Institutions
- 6.91%
Financial Efficiency
OneSource Specialty Pharma Limited’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is 0.27%.
- Return on Equity (ROE)
- -0.01
- Return on Assets (ROA)
- -0.01
- Return on Invested Capital (ROIC)
- 0.27%
- Return on Capital Employed (ROCE)
- 0.00
- Revenue Per Employee
- 8.49M
- Profits Per Employee
- -440.88K
- Employee Count
- 1,674
- Asset Turnover
- 0.17
- Inventory Turnover
- 2.20
Valuation Ratios
The current PE Ratio of OneSource Specialty Pharma Limited is -10665.33. OneSource Specialty Pharma Limited’s PEG ratio is 18.19.
- PE Ratio
- -10665.33
- PS Ratio
- 10.90
- PB Ratio
- 3.10
- Price to FCF
- -49.77
- Price to Operating Cash Flow
- -459.53
- PEG Ratio
- 18.19
Income Statement
In the last 12 months, OneSource Specialty Pharma Limited had revenue of 14.22B and earned -738.03M in profits. Earnings per share was -6.44.
- Revenue
- 14.22B
- Gross Profit
- 4.56B
- Operating Income
- 251.29M
- Pretax Income
- -919.61M
- Net Income
- -738.03M
- EBITDA
- 3.04B
- Earnings Per Share (EPS)
- -6.44
Cash Flow
In the last 12 months, operating cash flow was -399.21M and capital expenditures -3.29B, giving a free cash flow of -3.69B billion.
- Operating Cash Flow
- -399.21M
- Free Cash Flow
- -3.69B
- Free Cash Flow per Share
- -32.15
Dividends & Yields
OneSource Specialty Pharma Limited pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.97%
- Earnings Yield
- >-0.01%
Stock Price Statistics
- Beta
- 0.43
- 52-Week Price Change
- -10.38%
- 50-Day Moving Average
- 1523.61
- 200-Day Moving Average
- 1550.62
- Relative Strength Index (RSI)
- 61.69
- Average Volume (3m)
- 49.70K
Important Dates
OneSource Specialty Pharma Limited upcoming earnings date is Feb 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 27, 2026
- Next Earnings Date
- Feb 03, 2027
- Ex-Dividend Date
- ―
Financial Position
OneSource Specialty Pharma Limited as a current ratio of 0.99, with Debt / Equity ratio of 25.79%
- Current Ratio
- 0.99
- Quick Ratio
- 0.68
- Debt to Market Cap
- 0.08
- Net Debt to EBITDA
- 4.62
- Interest Coverage Ratio
- 0.21
Taxes
In the past 12 months, OneSource Specialty Pharma Limited has paid -181.58M in taxes.
- Income Tax
- -181.58M
- Effective Tax Rate
- 0.20
Enterprise Valuation
OneSource Specialty Pharma Limited EV to EBITDA ratio is 51.69, with an EV/FCF ratio of -55.51.
- EV to Sales
- 12.15
- EV to EBITDA
- 51.69
- EV to Free Cash Flow
- -55.51
- EV to Operating Cash Flow
- -512.57
Balance Sheet
OneSource Specialty Pharma Limited has INR 1.03B in cash and marketable securities with INR 0.00 in debt, giving a net cash position of INR 1.03B billion.
- Cash & Marketable Securities
- INR 1.03B
- Total Debt
- INR 0.00
- Net Cash
- INR 1.03B
- Net Cash Per Share
- INR 8.98
- Tangible Book Value Per Share
- INR 508.66
Margins
Gross margin is 35.16%, with operating margin of 6.39%, and net profit margin of -0.10%.
- Gross Margin
- 35.16%
- Operating Margin
- 6.39%
- Pretax Margin
- -1.20%
- Net Profit Margin
- -0.10%
- EBITDA Margin
- 23.51%
- EBIT Margin
- 6.39%
Analyst Forecast
The average price target for OneSource Specialty Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 10.66%
- EPS Growth Forecast
- -104.59%
Scores
- Smart Score
- ―
- AI Score
- 50
